NCT01946971View on ClinicalTrials.gov

Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Premature InfantsGastroesophageal Reflux
Interventions
DRUG

Lansoprazole

DRUG

Placebo

Trial Locations (1)

110-740

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01946971 - Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) | Biotech Hunter | Biotech Hunter